Annual Meeting

MCP to host immunopeptidomics session

Pierre Thibault
By Pierre Thibault
Feb. 11, 2022

The editorial leadership team of the journal Molecular & Cellular Proteomics has chosen four investigators to present their current research during a symposium at the 2022 American Society for Biochemistry and Molecular Biology Annual Meeting in Philadelphia.

Al Burlingame, MCP editor-in-chief, said, “This symposium will feature remarkable scientists who through their investigations have leveraged tools in immunology and molecular proteomics to uncover tumor antigens for the development of cancer vaccines.”

The session, titled “Exciting Biological Insights Revealed by Proteomics,” will be held at 3:15 p.m., Monday, April 4 in room 126A.

I will be chairing the session as well as giving a talk. I am a professor and principal investigator at the Institute for Research in Immunology and Cancer of Université de Montréal. My group employs mass spectrometry and proteogenomic approaches to identify tumor-specific antigens and to gain biological insights into their biogenesis.

I look forward to sharing the session with these three researchers:

Michal Bassani–Sternberg is an assistant professor at the department of oncology at the University of Lausanne. By leveraging high-sensitivity mass spectrometry, her group identifies clinically relevant cancer-specific major histocompatibility complex I ligands for personalized cancer immunotherapy.

Victor H. Engelhard is a professor of microbiology, immunology and cancer biology at the University of Virginia. His group made seminal contributions to the further understanding of immune responses to tumors and the identification of major histocompatibility complex–restricted tumor antigens.

Susan Klaeger is a research scientist in the proteomics platform at the Broad Institute of the Massachusetts Institute of Technology and Harvard University. Her work focuses on the application of proteomics to translational research and on the development of methods to study antigen presentation and prediction algorithms for human leukocyte antigen binding.

Read more about these speakers and their research in the following pages.

Bringing immunopeptidomics to the bedside
Michal Bassani–Sternberg

It’s what’s on the outside that counts
Victor H. Engelhard

Improving disease detection for personalized vaccines
Susan Klaeger

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Pierre Thibault
Pierre Thibault

Pierre Thibault is a professor and principal investigator at the Institute for Research in Immunology and Cancer of Université de Montréal.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Nights and days in the lab
BMB in Africa

Nights and days in the lab

June 23, 2022

With help from colleagues, mentors and others, Oluwaseyefunmi Adeniran pursues her dream of making scientific discoveries that improve human health.

A phage agent of change
BMB in Africa

A phage agent of change

June 22, 2022

Tolulope Oduselu, a student at the University of Ibadan in Nigeria, got hands-on research experience through a multinational program.

ASBMB names 2023 award winners
Announcement

ASBMB names 2023 award winners

June 21, 2022

Don’t miss their lectures at #DiscoverBMB in March in Seattle.

‘Life happens, but we keep pushing’
BMB in Africa

‘Life happens, but we keep pushing’

June 21, 2022

ASBMB member Adaude Amalunweze is a scientist and educator in Nigeria.

Protein Society announces 2022 awards
Member News

Protein Society announces 2022 awards

June 20, 2022

Among those recognized are ASBMB members Squire Booker, Daniel Herschlag and Nozomi Ando.

In memorian:  Nadrian Seeman
In Memoriam

In memorian: Nadrian Seeman

June 20, 2022

He was, a nanotechnologist who built the first self-assembling DNA structures and a member of the ASBMB since 1986.